# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001398733-25-000027
Filing Date
2025-11-05
Accepted
2025-11-05 16:04:15
Documents
25
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20251105.htm iXBRL | 8-K | 30891
2 | EX-99.1 | q32025-ex991earningsrelease.htm | EX-99.1 | 238733
3 | EX-99.2 | q32025supplementalearnin.htm | EX-99.2 | 16482
7 |  | aqstlogo.jpg | GRAPHIC | 14528
8 |  | q32025supplementalearnin001.jpg | GRAPHIC | 104223
9 |  | q32025supplementalearnin002.jpg | GRAPHIC | 289531
10 |  | q32025supplementalearnin003.jpg | GRAPHIC | 144682
11 |  | q32025supplementalearnin004.jpg | GRAPHIC | 124417
12 |  | q32025supplementalearnin005.jpg | GRAPHIC | 72269
13 |  | q32025supplementalearnin006.jpg | GRAPHIC | 40272
14 |  | q32025supplementalearnin007.jpg | GRAPHIC | 69829
15 |  | q32025supplementalearnin008.jpg | GRAPHIC | 92240
16 |  | q32025supplementalearnin009.jpg | GRAPHIC | 64162
17 |  | q32025supplementalearnin010.jpg | GRAPHIC | 37241
| Complete submission text file | 0001398733-25-000027.txt |  | 1881943

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20251105.xsd | EX-101.SCH | 1776
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20251105_lab.xml | EX-101.LAB | 21629
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20251105_pre.xml | EX-101.PRE | 12504
27 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20251105_htm.xml | XML | 2719

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251453821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)